S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Esperion TherapeuticsEvelo BiosciencesGraybug VisionFoghorn TherapeuticsVBI Vaccines
SymbolNASDAQ:ESPRNASDAQ:EVLONASDAQ:GRAYNASDAQ:FHTXNASDAQ:VBIV
Price Information
Current Price$29.04$9.99$15.85$13.71$3.09
52 Week RangeHoldHoldBuyBuyBuy
MarketRank™
Overall Score1.21.92.01.51.5
Analysis Score3.23.23.53.53.6
Community Score2.82.44.43.33.2
Dividend Score0.00.00.00.00.0
Ownership Score0.03.31.70.00.8
Earnings & Valuation Score0.00.60.60.60.0
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyBuy
Consensus Price Target$52.89$18.25$34.71$25.00$7.00
% Upside from Price Target82.12% upside82.68% upside119.02% upside82.35% upside126.54% upside
Trade Information
Market Cap$811.47 million$474.23 million$332.52 million$491.01 million$747.94 million
Beta1.481.46N/AN/A2.14
Average Volume943,150273,63049,37691,8198,156,787
Sales & Book Value
Annual Revenue$148.36 millionN/AN/AN/A$2.22 million
Price / Sales5.47N/AN/AN/A336.91
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.73 per share$1.88 per shareN/AN/A$0.50 per share
Price / Book39.78N/AN/AN/A6.18
Profitability
Net Income$-97,170,000.00$-85,470,000.00$-37,040,000.00N/A$-54,810,000.00
EPS($3.59)($2.67)N/AN/A($0.46)
Trailing P/E RatioN/AN/A0.000.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-46.15%N/AN/AN/A-2,837.73%
Return on Equity (ROE)-629.88%-159.17%N/AN/A-36.69%
Return on Assets (ROA)-41.43%-88.81%N/AN/A-28.29%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.59%N/AN/A0.10%
Current Ratio3.20%6.24%12.29%N/A9.06%
Quick Ratio3.08%6.24%12.29%N/A8.95%
Ownership Information
Institutional Ownership PercentageN/A84.57%70.66%N/A52.13%
Insider Ownership Percentage7.70%7.30%N/AN/A10.50%
Miscellaneous
Employees193982985123
Shares Outstanding27.94 million47.47 million20.98 million35.81 million242.05 million
Next Earnings Date5/5/2021 (Estimated)3/9/2021 (Confirmed)6/3/2021 (Estimated)N/A5/5/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.